CCL3 and type 1 diabetes mellitus: Additionally, we observed statistically higher eotaxin, sCD40L, and MIP-1α/CCL3 concentrations in the group of T1D patients with HbA1c ≥ 8% in comparison to T1D individuals with HbA1c < 8%.